The Boon and Bane of Covert Advertising
When pharmaceutical companies operate disease-awareness websites, they are required to give complete and accurate information to consumers, but at the same time, they are seeking to increase revenue. In most countries, direct-to-consumer advertising for prescription drugs (DTCA) is prohibited; thus,...
Saved in:
Main Authors: | Viorela Dan (Author), Sara Mahlmeister (Author) |
---|---|
Format: | Book |
Published: |
University of Zurich, IKMZ - Department of Communication and Media Research,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kangri: A boon or bane for Kashmiris
by: Iffat Hassan, et al.
Published: (2016) -
Use of Twitter in Neurology: Boon or Bane?
by: Mishra, Biswamohan, et al.
Published: (2021) -
Development of pediatric subspecialties: A boon or bane
by: Vyom Aggarwal
Published: (2023) -
Lasers in periodontics- A scientific boon or bane?
by: Vanaja Krishna Naik, et al.
Published: (2010) -
Dental journals in India: A boon or bane ?
by: N D Shashikiran
Published: (2013)